Feasibility of Multi-gene Panel Testing at the Time of Diagnosis for Patients With Ovarian Cancer
Completed
- Conditions
- Ovarian Cancer
- Registration Number
- NCT03656809
- Lead Sponsor
- NYU Langone Health
- Brief Summary
The purpose of this study is to determine the feasibility of routine referral to genetic counseling for all patients with a new diagnosis of epithelial ovarian, primary peritoneal or fallopian tube cancer.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 125
Inclusion Criteria
- All subjects must have a new diagnosis of epithelial ovarian, primary peritoneal, fallopian tube or extra- uterine mullerian cancer.
- All subjects must have either undergone primary surgery or be planning neoadjuvant chemotherapy for the treatment of ovarian, primary peritoneal or fallopian tube cancer.
- All subjects must be able to comprehend and communicate in English.
- All subjects must agree to participate.
- A previous diagnosis of cancer is not an exclusion criterion.
- Previous genetic screening is not an exclusion criterion.
Read More
Exclusion Criteria
- Patients who do not meet the above inclusion criteria.
- Patients with a diagnosis of a low malignant potential mullerian tumor.
- Patients who are not proficient in English language because the survey aspect of this study is comprised of 4 validated surveys that are only available in English language.
Read More
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Feasibility of timely routine referral to genetic counseling for all patients with a new diagnosis of epithelial ovarian, primary peritoneal or Fallopian tube cancer. 9 Months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
New York University School of Medicine
🇺🇸New York, New York, United States